DOSSIER · 13F Holders · Q1 2026
FDMT
4D MOLECULAR THERAPEUTICS IN
145 institutions still hold 4D MOLECULAR THERAPEUTICS IN as of Q1 2026. Tracked across SEC 13F-HR filings, with insider and 13D/G activity surfaced alongside.
CUSIP 35104E100·145 13F holders·last filed Mar 31, 2026
AI Holders Summary · Q1 2026
145 institutions reported FDMT in Q1 2026. JANUS HENDERSON GROUP PLC leads at 13.4% of the visible book.
Top holders
Sorted by position value. Source: SEC EDGAR 13F-HR filings.
Page 1 of 8
125 more holders available. Log in →